Download this datacard
Overview
Lobbying Costs
37,500€
Financial year: May 2016 - Apr 2017
Lobbyists (Full time equivalent)
8 Fte (8)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
British Generic Manufacturers Association (BGMA)
EU Transparency Register
535077929408-16 First registered on 21 Dec 2017
Goals / Remit
The British Generic Manufacturers Association (BGMA) represents the interests of UK-based manufacturers and suppliers of generic and biosimilar medicines and promotes the development and understanding of the generic and biosimilar medicines industry in the UK. Our members account for around 90% of the UK generic medicines market by volume.
Main EU files targeted
BGMA is interested in EU regulation and policies concerning the manufacture, marketing, licensing and maintenance of generic and biosimilar medicines.
Address
Head Office
65 Gresham Street
London EC2V 7NQ
UNITED KINGDOM -
People
Total lobbyists declared
8
Employment time Lobbyists 100% 8 Lobbyists (Full time equivalent)
8
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Mr Warwick Smith (Director-General)
Person with legal responsibility
Mr Warwick Smith (Director-General)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Trade and business associations
-
Networking
Affiliation
We are members of Medicines for Europe.
Member organisations
1. Accord Healthcare (a wholly owned subsidiary of Intas Pharmaceuticals)
2. Aristo Pharma Limited
3. Aspire Pharma Limited
4. Aurobindo Pharma Limited
5. B. Braun Medical Limited
6. Bowmed Ibisqus Limited
7. Bristol Laboratories Limited
8. Concordia International Corp.
9. Consilient Health Limited
10. Creo Pharma Limited
11. Dexcel Pharma Limited
12. Dr. Reddy’s Laboratories Limited
13. Fresenius Kabi Limited (a company of the Fresenius Kabi Group)
14. Genesis Pharmaceuticals Limited
15. hameln Pharmaceuticals Limited
16. Kent Pharmaceuticals (owned by DCC Vital)
17. Lupin Pharmaceuticals, Inc.
18. medac GmbH
19. Morningside Healthcare Limited
20. Mylan N.V.
21. Niche Generics Limited
22. Par Pharmaceutical (part of Endo International plc)
23. Rivopharm UK Limited
24. Rosemont Pharmaceuticals Limited (a Perrigo company)
25. Sandoz (a division of the Novartis Group)
26. Teva Pharmaceutical Industries Limited
27. Thornton and Ross Limited
28. Waymade Plc
29. Wockhardt Limited
30. Zentiva Group (a Sanofi company) -
Financial Data
Closed financial year
May 2016 - Apr 2017
Lobbying costs for closed financial year
37,500€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
None
Communication activities
None
Other activities
None declared
Meetings
Meetings
None declared